Benzophenone-3: Comprehensive review of the toxicological and human evidence with meta-analysis of human biomonitoring studies

Background: Benzophenone-3 (BP-3) and its major metabolite benzophenone-1 (BP-1) are widely used as UV filters in sunscreens and cosmetics to prevent sunburn and skin damage, or as stabilizers to prevent photodegradation in many commercial products. As a result, their presence is ubiquitous in the e...

ver descrição completa

Detalhes bibliográficos
Autores: Mustieles, Vicente, Balogh, Ria K., Axelstad, Marta, Montazeri, Parisa, 1988-, Márquez, Sandra, Vrijheid, Martine, Draskau, Monica K., Taxvig, Camilla, Peinado, Francisco M., Berman, Tamar, Frederiksen, Hanne, Fernández, Mariana F., Vinggaard, Anne Marie, Andersson, Anna-Maria
Formato: artículo
Estado:Versión publicada
Fecha de publicación:2023
País:España
Recursos:Universitat Pompeu Fabra
Repositorio:Repositorio Digital de la UPF
OAI Identifier:oai:repositori.upf.edu:10230/56304
Acesso em linha:http://hdl.handle.net/10230/56304
http://dx.doi.org/10.1016/j.envint.2023.107739
Access Level:acceso abierto
Palavra-chave:Benzophenone
Endocrine disruptor
HBM4EU
Oxybenzone
Risk assessment
Sunscreen
id ES_36c7b35ca2c27d2bf63077a3dcfaeec7
oai_identifier_str oai:repositori.upf.edu:10230/56304
network_acronym_str ES
network_name_str España
repository_id_str
dc.title.none.fl_str_mv Benzophenone-3: Comprehensive review of the toxicological and human evidence with meta-analysis of human biomonitoring studies
title Benzophenone-3: Comprehensive review of the toxicological and human evidence with meta-analysis of human biomonitoring studies
spellingShingle Benzophenone-3: Comprehensive review of the toxicological and human evidence with meta-analysis of human biomonitoring studies
Mustieles, Vicente
Benzophenone
Endocrine disruptor
HBM4EU
Oxybenzone
Risk assessment
Sunscreen
title_short Benzophenone-3: Comprehensive review of the toxicological and human evidence with meta-analysis of human biomonitoring studies
title_full Benzophenone-3: Comprehensive review of the toxicological and human evidence with meta-analysis of human biomonitoring studies
title_fullStr Benzophenone-3: Comprehensive review of the toxicological and human evidence with meta-analysis of human biomonitoring studies
title_full_unstemmed Benzophenone-3: Comprehensive review of the toxicological and human evidence with meta-analysis of human biomonitoring studies
title_sort Benzophenone-3: Comprehensive review of the toxicological and human evidence with meta-analysis of human biomonitoring studies
dc.creator.none.fl_str_mv Mustieles, Vicente
Balogh, Ria K.
Axelstad, Marta
Montazeri, Parisa, 1988-
Márquez, Sandra
Vrijheid, Martine
Draskau, Monica K.
Taxvig, Camilla
Peinado, Francisco M.
Berman, Tamar
Frederiksen, Hanne
Fernández, Mariana F.
Vinggaard, Anne Marie
Andersson, Anna-Maria
author Mustieles, Vicente
author_facet Mustieles, Vicente
Balogh, Ria K.
Axelstad, Marta
Montazeri, Parisa, 1988-
Márquez, Sandra
Vrijheid, Martine
Draskau, Monica K.
Taxvig, Camilla
Peinado, Francisco M.
Berman, Tamar
Frederiksen, Hanne
Fernández, Mariana F.
Vinggaard, Anne Marie
Andersson, Anna-Maria
author_role author
author2 Balogh, Ria K.
Axelstad, Marta
Montazeri, Parisa, 1988-
Márquez, Sandra
Vrijheid, Martine
Draskau, Monica K.
Taxvig, Camilla
Peinado, Francisco M.
Berman, Tamar
Frederiksen, Hanne
Fernández, Mariana F.
Vinggaard, Anne Marie
Andersson, Anna-Maria
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Benzophenone
Endocrine disruptor
HBM4EU
Oxybenzone
Risk assessment
Sunscreen
topic Benzophenone
Endocrine disruptor
HBM4EU
Oxybenzone
Risk assessment
Sunscreen
description Background: Benzophenone-3 (BP-3) and its major metabolite benzophenone-1 (BP-1) are widely used as UV filters in sunscreens and cosmetics to prevent sunburn and skin damage, or as stabilizers to prevent photodegradation in many commercial products. As a result, their presence is ubiquitous in the environment, wildlife and humans. Based on endocrine disruption concerns, international regulatory agencies are performing a closer evaluation. Objective and methods: This work aimed to comprehensively review the available human relevant evidence for safety issues in MEDLINE/PubMed in order to create a structured database of studies, as well as to conduct an integrative analysis as part of the Human Biomonitoring for Europe (HBM4EU) Initiative. Results: A total of 1,635 titles and abstracts were screened and 254 references were evaluated and tabulated in detail, and classified in different categories: i) exposure sources and predictors; ii) human biomonitoring (HBM) exposure levels to perform a meta-analysis; iii) toxicokinetic data in both experimental animals and humans; iv) in vitro and in vivo rodent toxicity studies; and v) human data on effect biomarkers and health outcomes. Our integrative analysis showed that internal peak BP-3 concentrations achieved after a single whole-body application of a commercially available sunscreen (4% w/w) may overlap with concentrations eliciting endocrine disrupting effects in vitro, and with internal concentrations causing in vivo adverse female reproductive effects in rodents that were supported by still limited human data. The adverse effects in rodents included prolonged estrous cycle, altered uterine estrogen receptor gene expression, endometrium hyperplasia and altered proliferation and histology of the mammary gland, while human data indicated menstrual cycle hormonal alterations and increased risk of uterine fibroids and endometriosis. Among the modes of action reported (estrogenic, anti-androgenic, thyroid, etc.), BP-3 and especially BP-1 showed estrogenic activity at human-relevant concentrations, in agreement with the observed alterations in female reproductive endpoints. The meta-analysis of HBM studies identified a higher concern for North Americans, showing urinary BP-3 concentrations on average 10 and 20 times higher than European and Asian populations, respectively. Discussion and conclusions: Our work supports that these benzophenones present endocrine disrupting properties, endorsing recent European regulatory efforts to limit human exposure. The reproducible and comprehensive database generated may constitute a point of departure in future risk assessments to support regulatory initiatives. Meanwhile, individuals should not refrain from sunscreen use. Commercially available formulations using inorganic UV filters that are practically not absorbed into systemic circulation may be recommended to susceptible populations.
publishDate 2023
dc.date.none.fl_str_mv 2023
2023
2023
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/10230/56304
http://dx.doi.org/10.1016/j.envint.2023.107739
url http://hdl.handle.net/10230/56304
http://dx.doi.org/10.1016/j.envint.2023.107739
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Environ Int. 2023 Jan 6;173:107739
info:eu-repo/grantAgreement/EC/H2020/733032
dc.rights.none.fl_str_mv http://creativecommons.org/licenses/by-nc-nd/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Elsevier
publisher.none.fl_str_mv Elsevier
dc.source.none.fl_str_mv reponame:Repositorio Digital de la UPF
instname:Universitat Pompeu Fabra
instname_str Universitat Pompeu Fabra
reponame_str Repositorio Digital de la UPF
collection Repositorio Digital de la UPF
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869405987975200768
spelling Benzophenone-3: Comprehensive review of the toxicological and human evidence with meta-analysis of human biomonitoring studiesMustieles, VicenteBalogh, Ria K.Axelstad, MartaMontazeri, Parisa, 1988-Márquez, SandraVrijheid, MartineDraskau, Monica K.Taxvig, CamillaPeinado, Francisco M.Berman, TamarFrederiksen, HanneFernández, Mariana F.Vinggaard, Anne MarieAndersson, Anna-MariaBenzophenoneEndocrine disruptorHBM4EUOxybenzoneRisk assessmentSunscreenBackground: Benzophenone-3 (BP-3) and its major metabolite benzophenone-1 (BP-1) are widely used as UV filters in sunscreens and cosmetics to prevent sunburn and skin damage, or as stabilizers to prevent photodegradation in many commercial products. As a result, their presence is ubiquitous in the environment, wildlife and humans. Based on endocrine disruption concerns, international regulatory agencies are performing a closer evaluation. Objective and methods: This work aimed to comprehensively review the available human relevant evidence for safety issues in MEDLINE/PubMed in order to create a structured database of studies, as well as to conduct an integrative analysis as part of the Human Biomonitoring for Europe (HBM4EU) Initiative. Results: A total of 1,635 titles and abstracts were screened and 254 references were evaluated and tabulated in detail, and classified in different categories: i) exposure sources and predictors; ii) human biomonitoring (HBM) exposure levels to perform a meta-analysis; iii) toxicokinetic data in both experimental animals and humans; iv) in vitro and in vivo rodent toxicity studies; and v) human data on effect biomarkers and health outcomes. Our integrative analysis showed that internal peak BP-3 concentrations achieved after a single whole-body application of a commercially available sunscreen (4% w/w) may overlap with concentrations eliciting endocrine disrupting effects in vitro, and with internal concentrations causing in vivo adverse female reproductive effects in rodents that were supported by still limited human data. The adverse effects in rodents included prolonged estrous cycle, altered uterine estrogen receptor gene expression, endometrium hyperplasia and altered proliferation and histology of the mammary gland, while human data indicated menstrual cycle hormonal alterations and increased risk of uterine fibroids and endometriosis. Among the modes of action reported (estrogenic, anti-androgenic, thyroid, etc.), BP-3 and especially BP-1 showed estrogenic activity at human-relevant concentrations, in agreement with the observed alterations in female reproductive endpoints. The meta-analysis of HBM studies identified a higher concern for North Americans, showing urinary BP-3 concentrations on average 10 and 20 times higher than European and Asian populations, respectively. Discussion and conclusions: Our work supports that these benzophenones present endocrine disrupting properties, endorsing recent European regulatory efforts to limit human exposure. The reproducible and comprehensive database generated may constitute a point of departure in future risk assessments to support regulatory initiatives. Meanwhile, individuals should not refrain from sunscreen use. Commercially available formulations using inorganic UV filters that are practically not absorbed into systemic circulation may be recommended to susceptible populations.This work is a direct product of the Human Biomonitoring for Europe Project (European Union Commission H2020-EJP-HBM4EU Grant agreement No 733032). The funder had no role in the study design, data collection or analysis, decision to publish, or preparation of the manuscript. V. Mustieles and P. Montazeri were under contract within the HBM4EU Initiative.Elsevier202320232023info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/pdfhttp://hdl.handle.net/10230/56304http://dx.doi.org/10.1016/j.envint.2023.107739reponame:Repositorio Digital de la UPFinstname:Universitat Pompeu FabraInglésEnviron Int. 2023 Jan 6;173:107739info:eu-repo/grantAgreement/EC/H2020/733032© 2023 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).http://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessoai:repositori.upf.edu:10230/563042026-06-12T07:21:37Z
score 15,812429